Literature DB >> 26400534

NBOMe: new potent hallucinogens--pharmacology, analytical methods, toxicities, fatalities: a review.

C Kyriakou1, E Marinelli, P Frati, A Santurro, M Afxentiou, S Zaami, F P Busardo.   

Abstract

OBJECTIVE: NBOMe is a class of emerging new psychoactive substances that has recently gained prominence in the drug abuse market. NBOMes are N-2-methoxy-benzyl substituted 2C class of hallucinogens, currently being marked online as "research chemicals" under various names: N-bomb, Smiles, Solaris, and Cimbi. This article reviews available literature on the pharmacology; the analytical methods currently used for the detection and quantification of NBOMe in biological matrices and blotters, together with intoxication cases and NBOMe-related fatalities.
MATERIALS AND METHODS: Relevant scientific articles were identified from Medline, Cochrane Central, Scopus, Web of Science, Science Direct, EMBASE and Google Scholar, through June 2015 using the following keywords: "NBOMe", "Nbomb", "Smiles", "intoxication", "toxicity" "fatalities", "death", "pharmacology", "5-HT2A receptor", "analysis" and "analytical methods". The main key word "NBOMe" was individually searched in association to each of the others.
RESULTS: The review of the literature allowed us to identify 43 citations on pharmacology, analytical methods and NBOMe-related toxicities and fatalities.
CONCLUSIONS: The high potency of NBOMes (potent agonists of 5-HT2A receptor) has led to several severe intoxications, overdose and traumatic fatalities; thus, their increase raises significant public health concerns. Moreover, due to the high potency and ease of synthesis, it is likely that their recreational use will become more widespread in the future. The publication of new data, case reports and evaluation of the NBOMes metabolites is necessary in order to improve knowledge and awareness within the forensic community.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26400534

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  12 in total

1.  Polysubstance use profiles among electronic dance music party attendees in New York City and their relation to use of new psychoactive substances.

Authors:  Fermín Fernández-Calderón; Charles M Cleland; Joseph J Palamar
Journal:  Addict Behav       Date:  2017-11-04       Impact factor: 3.913

2.  Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.

Authors:  Michael B Gatch; Sean B Dolan; Michael J Forster
Journal:  Behav Pharmacol       Date:  2017-08       Impact factor: 2.293

3.  Self-reported use of novel psychoactive substances among attendees of electronic dance music venues.

Authors:  Joseph J Palamar; Patricia Acosta; Scott Sherman; Danielle C Ompad; Charles M Cleland
Journal:  Am J Drug Alcohol Abuse       Date:  2016-06-17       Impact factor: 3.829

4.  Serotonin 2A Receptor (5-HT2AR) Activation by 25H-NBOMe Positional Isomers: In Vitro Functional Evaluation and Molecular Docking.

Authors:  Eline Pottie; Olga V Kupriyanova; Asher L Brandt; Robert B Laprairie; Vadim A Shevyrin; Christophe P Stove
Journal:  ACS Pharmacol Transl Sci       Date:  2021-02-25

Review 5.  Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants.

Authors:  Cristina Miliano; Giovanni Serpelloni; Claudia Rimondo; Maddalena Mereu; Matteo Marti; Maria Antonietta De Luca
Journal:  Front Neurosci       Date:  2016-04-19       Impact factor: 4.677

Review 6.  Correlation between Blood and Oral Fluid Psychoactive Drug Concentrations and Cognitive Impairment in Driving under the Influence of Drugs.

Authors:  Francesco Paolo Busardo; Simona Pichini; Manuela Pellegrini; Angelo Montana; Alfredo Fabrizio Lo Faro; Simona Zaami; Silvia Graziano
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 7.  Recent Trends in Analytical Methods to Determine New Psychoactive Substances in Hair.

Authors:  Chrystalla Kyriakou; Manuela Pellegrini; Oscar García-Algar; Enrico Marinelli; Simona Zaami
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

8.  Neurochemical and Behavioral Effects of a New Hallucinogenic Compound 25B-NBOMe in Rats.

Authors:  Adam Wojtas; Monika Herian; Mateusz Skawski; Małgorzata Sobocińska; Alejandro González-Marín; Karolina Noworyta-Sokołowska; Krystyna Gołembiowska
Journal:  Neurotox Res       Date:  2020-12-18       Impact factor: 3.911

9.  Neurotoxicological profile of the hallucinogenic compound 25I-NBOMe.

Authors:  Monika Herian; Adam Wojtas; Marzena Maćkowiak; Agnieszka Wawrzczak-Bargiela; Anna Solarz; Agnieszka Bysiek; Katarzyna Madej; Krystyna Gołembiowska
Journal:  Sci Rep       Date:  2022-02-21       Impact factor: 4.379

10.  The psychoactive drug 25B-NBOMe recapitulates rhabdomyolysis in zebrafish larvae.

Authors:  Genri Kawahara; Hideyuki Maeda; Ruri Kikura-Hanajiri; Ken-Ichi Yoshida; Yukiko K Hayashi
Journal:  Forensic Toxicol       Date:  2017-04-18       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.